alanine has been researched along with mitoxantrone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annable, T; Ayral-Kaloustian, S; Fojo, T; Greenberger, LM; Hari, M; Kaplan, J; Loganzo, F; May, MK; Minnick, AA; Morilla, DB; Musto, S; Poruchynsky, MS; Tan, X; Zask, A | 1 |
| Ban, M; Compston, A; Dubois, B; Goris, A; Gray, J; Maranian, M; Sawcer, S; Walton, A; Yeo, TW | 1 |
1 trial(s) available for alanine and mitoxantrone
| Article | Year |
|---|---|
CD24 Ala/Val polymorphism and multiple sclerosis.
Topics: Alanine; CD24 Antigen; Chemotaxis, Leukocyte; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Polymorphism, Single Nucleotide; Receptors, Chemokine; Valine | 2006 |
1 other study(ies) available for alanine and mitoxantrone
| Article | Year |
|---|---|
Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
Topics: Adenosine Triphosphate; Alanine; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Proliferation; Codon; Depsipeptides; Dimerization; DNA Damage; DNA, Complementary; Doxorubicin; Drug Resistance, Neoplasm; Humans; Mice; Mice, Nude; Mitoxantrone; Models, Molecular; Multidrug Resistance-Associated Proteins; Mutation; Neoplasm Proteins; Neoplasm Transplantation; Oligopeptides; Point Mutation; Protein Conformation; Sequence Analysis, DNA; Sodium Azide; Time Factors; Tubulin; Vinblastine | 2004 |